Dr. Pam Taub is a cardiologist who focuses on preventive cardiology. She practices with UC San Diego Health in the La Jolla and San Diego area and is a Professor of Medicine at the UC San Diego School of Medicine, Division of Cardiovascular Medicine (https://profiles.ucsd.edu/pam.taub).
She earned her MD at Boston University School of Medicine, completed internal medicine residency at the University of Washington Medical Center in Seattle, and did her cardiovascular medicine fellowship at UC San Diego (https://profiles.ucsd.edu/pam.taub, https://www.cardiometabolichealth.org/faculty/pam-taub/, https://cardiology.ucsd.edu/research/labs/preventive/about/pam-taub.html). She is the founding director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center and directs preventive cardiology at UC San Diego (https://profiles.ucsd.edu/pam.taub, https://www.doximity.com/cv/pam-taub-md-slash-1).
Much of her public work involves research and guideline writing. She has been credited with more than 100 publications, book chapters and abstracts, and she runs research funded by the NIH, the Department of Defense and the American Heart Association (https://profiles.ucsd.edu/pam.taub, https://reachmd.com/profiles/pam-r-taub-md-facc-faspc/j1D0qv/biography/). She served on the writing committee for the 2025 ACC/AHA guideline on acute coronary syndromes and the 2022 ACC expert consensus pathway on heart problems after COVID-19 (https://www.jacc.org/doi/abs/10.1016/j.jacc.2024.11.009, https://pubmed.ncbi.nlm.nih.gov/35307156/). She was a co-corresponding author on a UC San Diego and Salk Institute study of time-restricted eating in firefighters (https://today.ucsd.edu/story/study-time-restricted-eating-improves-cardiovascular-health-for-firefighters).
Federal Open Payments records for 2021 through 2025 list $887,116.29 in industry payments to her across 637 records, with the largest amounts from Novo Nordisk, Medtronic and Boehringer Ingelheim. Payments from drug and device makers to physicians are common and legal, and are often tied to research, consulting or speaking work; patients can ask a doctor directly how such relationships may relate to their care.
Federal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.
2021 to 2025
$887,116
637 payments
| 2021 | $87,837 |
| 2022 | $131,642 |
| 2023 | $155,269 |
| 2024 | $247,175 |
| 2025 | $265,193 |
Top payers
- Novo Nordisk AS$171,109
- Novo Nordisk Inc$97,883
- Medtronic, Inc.$76,919
- Boehringer Ingelheim Pharmaceuticals, Inc.$71,625
- Boehringer Ingelheim International GmbH$53,091
Payment types
- Consulting Fee$495,636
- Travel and Lodging$198,514
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$167,399
- Food and Beverage$15,381
- Compensation for serving as faculty or as a speaker for a medical education program$7,913
A word of caution about these numbers
A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.
As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.
Summary prepared with AI assistance from the public sources linked above. It is not a review, a rating, or an endorsement.